D. E. Shaw & Co., Inc. Cor Medix Inc. Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Cor Medix Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 130,244 shares of CRMD stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

130,244

Previous 129,371 0.67%

Holding current value

$1.05 Million

Previous $548,000 2.74%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.08 - $6.39 $3,561 - $5,578	873 Added 0.67%	130,244 $563,000
Q1 2024 May 15, 2024	SELL	$2.94 - $4.24 $40,883 - $58,961	-13,906 Reduced 9.71%	129,371 $548,000
Q4 2023 Feb 14, 2024	SELL	$3.0 - $4.01 $128,916 - $172,317	-42,972 Reduced 23.07%	143,277 $538,000
Q3 2023 Nov 14, 2023	BUY	$3.6 - $4.46 $485,802 - $601,854	134,945 Added 263.03%	186,249 $689,000
Q2 2023 Aug 14, 2023	SELL	$3.94 - $5.8 $295,519 - $435,029	-75,005 Reduced 59.38%	51,304 $203,000
Q1 2023 May 15, 2023	SELL	$3.22 - $4.61 $59,656 - $85,409	-18,527 Reduced 12.79%	126,309 $522,000
Q4 2022 Feb 14, 2023	BUY	$2.81 - $4.45 $262,698 - $416,017	93,487 Added 182.06%	144,836 $611,000
Q3 2022 Nov 14, 2022	BUY	$2.82 - $7.52 $105,831 - $282,218	37,529 Added 271.56%	51,349 $145,000
Q2 2022 Aug 15, 2022	BUY	$2.73 - $5.61 $6,347 - $13,043	2,325 Added 20.23%	13,820 $56,000
Q1 2022 May 16, 2022	BUY	$3.83 - $6.24 $44,025 - $71,728	11,495 New	11,495 $63,000
Q1 2021 May 17, 2021	SELL	$6.84 - $17.58 $292,895 - $752,793	-42,821 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.0 - $9.15 $214,105 - $391,812	42,821 New	42,821 $318,000
Q1 2020 May 15, 2020	SELL	$2.35 - $7.08 $71,219 - $214,566	-30,306 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.96 - $7.75 $150,317 - $234,871	30,306 New	30,306 $221,000

Others Institutions Holding CRMD

# of Institutions

101

Shares Held

16.9M

Call Options Held

70.5K

Put Options Held

358K

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $334M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account